Bone Growth Stimulators Market Size, Share & Trends Analysis Report
出版社 | Grand View Research |
出版年月 | 2024年8月 |
ページ数 | 80 |
価格タイプ | シングルユーザライセンス |
価格 | USD 5,950 |
種別 | 英文調査報告書 |
Bone Growth Stimulators Market Growth & Trends
The global bone growth stimulators market size is anticipated to reach USD 1.53 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.1% from 2024 to 2030.
世界の骨成長刺激剤の市場規模は 2030 年までに 15 億 3,000 万米ドルに達すると予想されています。市場は 2024 年から 2030 年にかけて 5.1% の CAGR で成長すると予測されています。
Escalating demand for noninvasive and minimally invasive treatments is a major factor estimated to boost market growth during the forecast period. Some advantages offered by minimally invasive surgeries are smaller incisions, low risk of infections, speedy recovery, shorter stay at the hospital, reduced scarring, and minimal blood loss during surgery. Thus, there is high adoption of Bone Morphogenetic Proteins (BMP) and Platelet-rich Plasma (PRP) for minimally invasive spinal and orthopedic surgeries, which is expected to boost the market growth.

The rising number of trauma and accident cases is another major factor projected to support the growth of the bone growth stimulator market. According to WHO, around 20 to 50 million people are injured every year due to road accidents. Road accidents and trauma are likely to result in severe spinal injuries as well as delayed union or nonunion of bone fractures, which is projected to drive demand for bone growth stimulators.
Bone Growth Stimulators Market Report Scope
Report Attribute | Details |
Market size value in 2024 | USD 1.14 billion |
Revenue forecast in 2030 | USD 1.53 billion |
Growth rate | CAGR of 5.1% from 2024 to 2030 |
Base year for estimation | 2023 |
Historical data | 2018 – 2022 |
Forecast period | 2024 – 2030 |
Quantitative units | Revenue in USD billion and CAGR from 2024 to 2030 |
Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered | Product, application, end-use, region |
Regional scope | North America, Europe, Asia Pacific, Latin America, MEA |
Country scope | U.S., Canada, Mexico, Germany, UK, France, Spain, Denmark, Sweden, Norway, China, Japan, India, South Korea, Australia, Thailand, Brazil, Argentina, KSA, UAE, South Africa |
Key companies profiled | Orthofix Holdings; Inc. Medtronic; Zimmer Biomet; DePuy Synthes; Arthrex, Inc. Bioventus ;DJO Global, Inc.;Ossatec Benelux; BTT Health GmbH; IGEA; Isto Biologics. |
Customization scope | Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Bone Growth Stimulators Market Report Highlights
• Bone growth stimulation devices segment was the largest revenue grossing segment of the market in 2023 owing to high demand for noninvasive treatments by patients as well as product advancements.
• PRP segment is estimated to grow at the highest CAGR during the forecast period owing to its growing popularity for bone and soft tissue healing, as well as its favorable safety profile and potential promising outcome for the development of regenerative treatments.
• In the application segment, the spinal fusion surgeries segment accounted for the largest share in 2023 and is projected to maintain its dominance during the forecast period owing to the escalating number of spinal injuries, fractures, and spinal stenosis.
• The hospitals segment accounted for the largest share in the overall market and is expected to maintain its dominance during the study period due to escalating number of admissions of patients suffering from traumatic injuries, road accidents, spinal injuries, and bone fractures.
• North America dominated the overall market in 2023 mainly due to the existence of several leading medical device companies in this region and highly developed healthcare infrastructure.
• The Asia Pacific bone growth stimulator market is projected to grow at the highest rate during the forecast period. The rising number of road accidents and developing healthcare infrastructure in Asian countries, including China, India, and Indonesia, are major factors contributing to growth in this region.
Table of Contents
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Global Bone Growth Stimulators Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Global Bone Growth Stimulators Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Global Bone Growth Stimulators Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Bone Growth Stimulators Market: Product Movement Analysis, 2023 & 2030 (USD Billion)
4.3. Bone growth stimulation devices
4.3.1. Bone Growth Stimulation Devices Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
4.4. Bone Morphogenetic Proteins (BMP)
4.4.1. Bone Morphogenetic Proteins (BMP) Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
4.5. Platelet-Rich Plasma (PRP)
4.5.1. Platelet-Rich Plasma (PRP) Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
Chapter 5. Global Bone Growth Stimulators Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Bone Growth Stimulators Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
5.3. Spinal fusion surgeries
5.3.1. Spinal fusion surgeries Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
5.4. Delayed union & nonunion bone fractures
5.4.1. Delayed union & nonunion bone fractures Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
5.5. Orthopedic trauma surgeries
5.5.1. Orthopedic trauma surgeries Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
5.6. Other Accessories
5.6.1. Other Accessories Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
Chapter 6. Globe Bone Growth Stimulators Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Bone Growth Stimulators Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
6.3. Hospitals
6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
6.4. Specialized Orthopedic Clinics
6.4.1. Specialized Orthopedic Clinics Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
6.5. Home Care Settings
6.5.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
6.6. Ambulatory Surgical Centers
6.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
Chapter 7. Globe Bone Growth Stimulators Market: Regional Estimates & Trend Analysis
7.1. Bone Growth Stimulators Market Share, By Region, 2023 & 2030 (USD Billion)
7.2. North America
7.2.1. North America Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.2.2. U.S.
7.2.2.1. U.S. Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.2.3. Canada
7.2.3.1. Canada Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.2.4. Mexico
7.2.4.1. Mexico Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.3. Europe
7.3.1. Europe Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.3.2. U.K.
7.3.2.1. U.K. Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.3.3. Germany
7.3.3.1. Germany Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.3.4. Italy
7.3.4.1. Italy Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.3.5. Spain
7.3.5.1. Spain Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.3.6. Denmark
7.3.6.1. Denmark Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.3.7. Sweden
7.3.7.1. Sweden Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.3.8. Norway
7.3.8.1. Norway Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.4. Asia Pacific
7.4.1. Asia Pacific Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.4.2. China
7.4.2.1. China Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.4.3. Japan
7.4.3.1. Japan Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.4.4. India
7.4.4.1. India Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.4.5. South Korea
7.4.5.1. South Korea Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.4.6. Australia
7.4.6.1. Australia Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.4.7. Thailand
7.4.7.1. Thailand Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.5. Latin America
7.5.1. Latin America Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.5.2. Brazil
7.5.2.1. Brazil Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.5.3. Argentina
7.5.3.1. Argentina Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.6.2. Saudi Arabia
7.6.2.1. Saudi Arabia Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.6.3. UAE
7.6.3.1. UAE Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.6.4. South Africa
7.6.4.1. South Africa Bone Growth Stimulators Market Estimates and Forecasts, 2018 – 2030 (USD Billion)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.5. Orthofix Holdings, Inc.
8.5.1. Participant’s Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Recent Developments/ Strategic Initiatives
8.6. Medtronic
8.6.1. Participant’s Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Recent Developments/ Strategic Initiatives
8.7. Zimmer Biomet
8.7.1. Participant’s Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Recent Developments/ Strategic Initiatives
8.8. DePuy Synthes
8.8.1. Participant’s Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Recent Developments/ Strategic Initiatives
8.9. Arthrex, Inc.
8.9.1. Participant’s Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Recent Developments/ Strategic Initiatives
8.10. Bioventus
8.10.1. Participant’s Overview
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Recent Developments/ Strategic Initiatives
8.11. DJO Global, Inc.
8.11.1. Participant’s Overview
8.11.2. Financial Performance
8.11.3. Product Benchmarking
8.11.4. Recent Developments/ Strategic Initiatives
8.12. Ossatec benelux
8.12.1. Participant’s Overview
8.12.2. Financial Performance
8.12.3. Product Benchmarking
8.12.4. Recent Developments/ Strategic Initiatives
8.13. Altis biologics
8.13.1. Participant’s Overview
8.13.2. Financial Performance
8.13.3. Product Benchmarking
8.13.4. Recent Developments/ Strategic Initiatives
8.14. BTT health GMBH
8.14.1. Participant’s Overview
8.14.2. Financial Performance
8.14.3. Product Benchmarking
8.14.4. Recent Developments/ Strategic Initiatives
8.15. IGEA
8.15.1. Participant’s Overview
8.15.2. Financial Performance
8.15.3. Product Benchmarking
8.16. Isto Biologics
8.16.1. Participant’s Overview
8.16.2. Financial Performance
8.16.3. Product Benchmarking
8.16.4. Recent Developments/ Strategic Initiatives
Grand View Researchについて
Grand View Research(グランドビューリサーチ) はインドと米国を拠点とする市場調査およびコンサルティング会社です。世界中主要 25ヵ国・ 46 業界に関する豊富なデータベースを活用した市場情報は世界の企業団体に活用・引用されています。日本からのレポートのご注文・ご購入相談はお気軽にお問い合わせください。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ 1
シングルユーザ | チーム | エンタープライズ |
USD 2,950 | USD 3,950 | USD 5,950 |
ライセンスタイプ 2
シングルユーザ | チーム | エンタープライズ |
USD 3,950 | USD 4,950 | USD 6,950 |
ライセンスタイプ 3
シングルユーザ | チーム | エンタープライズ |
USD 4,950 | USD 5,950 | USD 7,950 |
ライセンスタイプ 4
シングルユーザ | チーム | エンタープライズ |
USD 5,950 | USD 6,950 | USD 8,950 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨(定価)を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料(ハンドリングチャージ)無料。
- ライセンス
- シングルユーザライセンス(インディビジュアルライセンス)
- 1名のみレポートファイル(印刷不可)をご利用いただけます。
- チームライセンス
- 同一企業(関連会社除く)内5名まで共有可能です。印刷可能な電子ファイルをご提供いたします。
- コーポレートライセンス
- 同一企業および関連会社内で人数無制限で共有可能です。印刷可能な電子ファイルをご提供いたします。
- 「関連会社」の範囲についてはお気軽にお問い合わせください。
- シングルユーザライセンス(インディビジュアルライセンス)
- 納品形態
- オンラインダウンロード
- 納期
- ご注文後1~7営業日 ※レポートにより異なります。
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
最新出版レポート